| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in RYTM over the last quarter tilts toward selling: insiders offloaded a net 258,450 shares worth roughly $28.8M.
RYTM sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 239.3K | $1.45M | - | |
| CFO | 114.0K | $11.93M | - | |
| VP | 55.7K | $6.54M | - | |
| Other | 29.4K | - | - | |
| Other | 15.9K | $1.91M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 7, 2020 | Foley Todd82 | Director | Sell | 1,826 | $20.00 | $36,522.00 | - | |
| Apr 29, 2020 | Foley Todd82 | Director | Sell | 36,223 | $20.10 | $728,015.46 | -1.6% | |
| Apr 1, 2020 | Foley Todd82 | Director | Sell | 34,570 | $15.13 | $523,153.48 | -1.5% | |
| Mar 26, 2020 | Foley Todd82 | Director | Sell | 2,300 | $15.04 | $34,592.00 | - | |
| Mar 20, 2020 | Foley Todd82 | Director | Sell | 1,100 | $15.00 | $16,500.00 | - | |
| Mar 19, 2020 | Foley Todd82 | Director | Sell | 30,634 | $15.11 | $463,031.70 | -1.3% | |
| Dec 27, 2019 | Desikan Nithya | Chief Commercial Officer | Sale+OE | 35,181 | $22.79 | $801,771.47 | -54.8% | |
| Dec 12, 2019 | Foley Todd82 | Director | Sell | 17,362 | $25.11 | $435,991.62 | -0.7% | |
| Dec 10, 2019 | Foley Todd82 | Director | Sell | 64,034 | $25.25 | $1,616,799.84 | -2.6% | |
| Dec 3, 2019 | Foley Todd82 | Director | Sell | 42,143 | $22.15 | $933,443.39 | -1.7% |